SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
Study Number: 

I 259614

Phase: 
II
Trial categories: 
Glioblastoma
Brain Cancer
Immunotherapy
Vaccines
Principal Investigator: